Evidence map›Paper›PMID 30566459›Full record

ArticlePloS one2018

Noncontact recognition of fluorescently labeled objects in deep tissue via a novel optical light beam arrangement.

Andreas Hien, Marc Pretze, Frank Braun, Edgar Schäfer, Tim Kümmel, Mareike Roscher, Daniel Schock-Kusch, Jens Waldeck, Bernhard Müller, Carmen Wängler and 2 more

Abstract read
In one paragraph

Article in PloS one, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Preclinical Evaluation of Stable Integrin αPharmaceuticals (Basel, Switzerland) · 2025
    Article
  2. Radiosynthesis of StablePharmaceuticals (Basel, Switzerland) · 2023
    Article
  3. αNanomaterials (Basel, Switzerland) · 2021
    Article
  4. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Andreas HienInstitute of Process Control and Innovative Energy Conversion, Mannheim University of Applied Sciences, Mannheim, Germany.ORCID 0000-0002-8572-0626
Marc PretzeMolecular Imaging and Radiochemistry, Department of Clinical Radiology and Nuclear Medicine, Medical Faculty Mannheim of Heidelberg University, Mannheim, Germany.ORCID 0000-0002-6432-5694
Frank BraunInstitute of Process Control and Innovative Energy Conversion, Mannheim University of Applied Sciences, Mannheim, Germany.
Edgar SchäferInstitute of Process Control and Innovative Energy Conversion, Mannheim University of Applied Sciences, Mannheim, Germany.
Tim KümmelInstitute of Process Control and Innovative Energy Conversion, Mannheim University of Applied Sciences, Mannheim, Germany.
Mareike RoscherMolecular Imaging and Radiochemistry, Department of Clinical Radiology and Nuclear Medicine, Medical Faculty Mannheim of Heidelberg University, Mannheim, Germany.
Daniel Schock-KuschInstitute of Process Control and Innovative Energy Conversion, Mannheim University of Applied Sciences, Mannheim, Germany.
Jens WaldeckBruker BioSpin MRI GmbH, Ettlingen, Germany.
Bernhard MüllerProxiVision GmbH, Bensheim, Germany.
Carmen WänglerBiomedical Chemistry, Department of Clinical Radiology and Nuclear Medicine, Medical Faculty Mannheim of Heidelberg University, Mannheim, Germany.
Matthias RädleInstitute of Process Control and Innovative Energy Conversion, Mannheim University of Applied Sciences, Mannheim, Germany.
Björn WänglerMolecular Imaging and Radiochemistry, Department of Clinical Radiology and Nuclear Medicine, Medical Faculty Mannheim of Heidelberg University, Mannheim, Germany.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

To date, few optical imaging systems are available in clinical practice to perform noninvasive measurements transcutaneously. Instead, functional imaging is performed using ionizing radiation or intense magnetic fields in most cases. The applicability of fluorescence imaging (e.g., for the detection of fluorescently labeled objects, such as tumors) is limited due to the restricted tissue penetration of light and the required long exposure time. Thus, the development of highly sensitive and easily manageable instruments is necessary to broaden the utility of optical imaging. To advance these developments, an improved fluorescence imaging system was designed in this study that operates on the principle of noncontact laser-induced fluorescence and enables the detection of fluorescence from deeper tissue layers as well as real-time imaging. The high performance of the developed optical laser scanner results from the combination of specific point illumination, an intensified charge-coupled device (ICCD) detector with a novel light trap, and a filtering strategy. The suitability of the laser scanner was demonstrated in two representative applications and an in vivo evaluation. In addition, a comparison with a planar imaging system was performed. The results show that the exposure time with the developed laser scanner can be reduced to a few milliseconds during measurements with a penetration depth of up to 32 mm. Due to these short exposure times, real-time fluorescence imaging can be easily achieved. The ability to measure fluorescence from deep tissue layers enables clinically relevant applications, such as the detection of fluorescently labeled malignant tumors.

Indexed as

LasersPhantoms, ImagingFluorescenceHumansOptical Imaging

Identifiers

PMID30566459
PMCPMC6300195

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.